Indivumed Therapeutics is a global oncology company, with a focus on bioinformatics and multi-omics-based oncology R&D. Utilizing the same high-quality multi-omics and clinical datasets all the way through, we use AI-assisted advanced analytics to drive biomarker discovery as well as novel target identification and validation for potential therapies.

Get a brief overview of our work and what we have in store for you at ESMO.